Tunisia Introduces Revolutionary Weekly Diabetes Treatment
Translated from French, summarized and contextualized by DistantNews.
TLDR
- Tunisia is introducing a new type of injectable medication for type 2 diabetes, administered weekly via a pen device.
- The treatment not only regulates blood sugar but also aids in weight loss and improves cardiovascular health, with proven safety for kidney patients.
- Despite its benefits and global availability, the medication will require a specialist's prescription and costs 355 Tunisian dinars per month, with negotiations underway for potential insurance coverage.
Tunisia's healthcare landscape is set to be transformed with the official introduction of a groundbreaking new medication for type 2 diabetes. This revolutionary treatment, delivered via a convenient monthly pen injector, marks a significant step forward in managing a condition that affects a staggering 23% of the Tunisian population.
The new device is presented in the form of an injector pen containing four doses, which allows for a single administration per week.
The new drug offers a multi-faceted approach, going beyond simple blood sugar control to also promote weight loss and enhance cardiovascular health. Crucially, it has demonstrated safety for patients with kidney issues, a common complication for those living with diabetes, particularly in a country where overweight and obesity are prevalent.
Its benefits extend to the improvement of several fundamental health indicators, including the reduction of body weight and the strengthening of cardiovascular health, while ensuring safety of use for patients suffering from kidney failure.
While the Ministry of Health has approved the medication, its access will be carefully managed. A specialist's prescription will be mandatory, ensuring patients receive optimal therapeutic guidance. The cost, set at 355 Tunisian dinars for a month's supply, presents a potential barrier, though discussions are ongoing with the National Health Insurance Fund (CNAM) to explore coverage options for insured individuals.
The cost of a box, covering a full month of treatment, is set at 355 Tunisian dinars.
This development is particularly vital given the high prevalence of diabetes and associated health risks in Tunisia. The availability of more effective and user-friendly treatments like this one offers a much-needed beacon of hope for improving the quality of life for countless patients.
Negotiations will begin soon with the National Health Insurance Fund (CNAM) to study the modalities of coverage for this medication for social security beneficiaries.
DistantNews Editorial
Originally published by La Presse in French. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.
More Stories
From Our Blog
What Gets Lost (and Found) When News Is Translated
The Critical Role of Diaspora Media in Global News
What Travellers Should Know About Countries with Restricted Press
A Digital Nomad's Guide to Following Local News
How the Same Story Looks Different in Different Countries
